Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Cryptococcus neoformans infection in hematologic malignancies].

S Vigouroux1, O Morin, N Milpied

  • 1Service d'hématologie clinique, Hôtel-Dieu, CHU, Nantes, France.

La Revue De Medecine Interne
|December 8, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dramatic recovery in a patient with anti-myelin-associated glycoprotein neuropathy.

Revue neurologique·2020
Same author

Ibrutinib, a Bruton's tyrosine kinase inhibitor, a new risk factor for cryptococcosis.

Medecine et maladies infectieuses·2020
Same author

Carboplatin instead of cisplatin in combination with dexamethasone, high-dose cytarabine with or without rituximab (DHAC+/-R) is an effective treatment with low toxicity in Hodgkin's and non-Hodgkin's lymphomas.

Annals of hematology·2017
Same author

Second-degree relative donors for T-replete haploidentical allogeneic stem cell transplantation with high-dose post-transplant cyclophosphamide: toward crossing the major HLA barrier.

Bone marrow transplantation·2017
Same author

Multiple myeloma treatment at relapse after autologous stem cell transplantation: A practical analysis.

Cancer treatment reviews·2016
Same author

Rituximab maintenance after autologous stem cell transplantation prolongs response duration in non-naive rituximab follicular lymphoma patients: a single institution experience.

Annals of hematology·2016
Same journal

[Abdominal pain, fever and arthralgia in a 49-year-old woman].

La Revue de medecine interne·2026
Same journal

[Cardiorespiratory functional disorders: A transnosologic approach].

La Revue de medecine interne·2026
Same journal

[Diagnostic evaluation for suspected polycythemia].

La Revue de medecine interne·2026
Same journal

Heart involvements in systemic sclerosis beyond pulmonary hypertension: From conduction, rhythm and function defects to coronary artery disease.

La Revue de medecine interne·2026
Same journal

[Acute intermittent porphyria: When diagnostic errance jeopardizes patient health].

La Revue de medecine interne·2026
Same journal

Autosomal dominant polycystic kidney disease: Current perspectives in 2026.

La Revue de medecine interne·2026
See all related articles

Cryptococcus neoformans infections are a risk for patients with hematological malignancies, especially after fludarabine treatment. Early diagnosis is crucial for prompt management of this opportunistic infection.

Area of Science:

  • Infectious Diseases
  • Hematology
  • Oncology

Background:

  • Cryptococcus is an opportunistic pathogen, frequently complicating advanced HIV infection.
  • Patients with hematological malignancies are particularly susceptible to opportunistic infections.
  • This study focuses on Cryptococcus neoformans infections in patients with hematological disorders.

Observation:

  • Six cases of cryptococcosis were identified in hematological malignancy patients over a decade.
  • Infections were associated with lymphoproliferative disorders, including chronic lymphocytic leukemia and lymphomas.
  • Fludarabine therapy, leading to significant lymphocytopenia, was noted in four cases.

Findings:

  • Fludarabine treatment appears to promote the spread of cryptococcal infections.

Related Experiment Videos

  • Cell-mediated immunity is critical for defense against Cryptococcus neoformans.
  • The drug's impact on CD4 cells may impair the immune response.

    • Implications:

    • Consider cryptococcal infection in hematological patients with respiratory, neurological, or skin symptoms.
    • Prompt diagnosis and treatment are essential for managing cryptococcosis in this vulnerable population.
    • Fludarabine's role in cryptococcal infections warrants further investigation and clinical consideration.